RY 174.39 2.4016% SHOP 149.115 2.5974% TD-PFM 24.63 -0.0811% TD-PFL 24.7 0.2028% TD 78.325 0.1214% ENB 60.6 1.3039% BN 80.4 1.9787% TRI 226.27 0.7525% CNQ 48.285 2.2771% CP 104.53 1.6038% CNR 151.74 1.5459% BMO 132.69 0.9203% BNS 78.845 0.1715% CSU 4600.2002 2.157% CM 91.15 0.474% MFC 45.79 1.6878% ATD 78.38 1.5285% NGT 60.14 0.0499% TRP 70.15 1.977% SU 57.44 0.5954%
Last update at 2024-11-21T21:10:00Z
The Lithium Price Cycle Has Bottomed. What To Expect Next For These Stocks.
Fri 08 Nov 24, 05:35 PMIs Albemarle Corporation (ALB) the Best High Growth Lithium Stock to Invest In?
Fri 18 Oct 24, 11:51 AMState Street Corp's Strategic Acquisition of Albemarle Corp Shares
Wed 16 Oct 24, 07:01 PMIs Albemarle Corporation (ALB) Positioned for Growth in the EV Market According to Hedge Funds?
Mon 14 Oct 24, 12:37 PMHow To Play The Comeback in Lithium
Thu 10 Oct 24, 11:00 PMRio Tinto's acquisition highlights M&A value of Lithium assets: Wells Fargo
Thu 10 Oct 24, 01:50 PMRio Tinto Buys Fallen Lithium Stock As Battery Metal Price Bottoms; Albemarle Gets Target Boost
Wed 09 Oct 24, 01:49 PMHere is What to Know Beyond Why Albemarle Corporation (ALB) is a Trending Stock
Mon 07 Oct 24, 01:00 PMRio Tinto Confirms Interest In Arcadium Lithium, Shares Surge
Mon 07 Oct 24, 11:16 AMAlbemarle Stock Surge Despite Uncertainty of Rio Tinto's Lithium Acquisitions
Fri 04 Oct 24, 03:33 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 2433.44M | 133.62M | 373.52M | 562.95M | 794.70M |
| Minority interest | 125.31M | -76.27000M | 70.85M | 161.33M | 173.79M |
| Net income | 2042.86M | 123.67M | 375.76M | 533.23M | 693.56M |
| Selling general administrative | 524.14M | 441.48M | 429.83M | 533.37M | 446.09M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 3074.59M | 997.97M | 994.85M | 1257.78M | 1217.26M |
| Reconciled depreciation | 300.84M | 254.00M | 231.98M | 213.48M | 200.70M |
| Ebit | 2470.06M | -100.87700M | 505.81M | 666.12M | 435.98M |
| Ebitda | 2865.66M | 153.12M | 678.62M | 834.13M | 636.68M |
| Depreciation and amortization | 395.60M | 254.00M | 172.81M | 168.01M | 200.70M |
| Non operating income net other | 858.63M | -507.57000M | 68.34M | - | 24.83M |
| Operating income | 2470.06M | -100.87700M | 505.81M | 666.12M | 911.54M |
| Other operating expenses | 4841.64M | 2825.49M | 2623.10M | 2923.30M | 2673.84M |
| Interest expense | 122.97M | 61.48M | 73.12M | 57.70M | 52.41M |
| Tax provision | 390.59M | 29.45M | 54.42M | 88.16M | 144.83M |
| Interest income | 122.97M | 61.48M | 68.32M | 78.66M | 72.26M |
| Net interest income | -122.97300M | -61.47600M | -73.11600M | -57.69500M | -52.40500M |
| Extraordinary items | - | - | - | - | 21.90M |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 390.59M | 29.45M | 54.42M | 88.16M | 144.83M |
| Total revenue | 7320.10M | 3327.96M | 3128.91M | 3589.43M | 3374.95M |
| Total operating expenses | 596.13M | 495.51M | 489.04M | 591.65M | 516.14M |
| Cost of revenue | 4245.52M | 2329.99M | 2134.06M | 2331.65M | 2157.69M |
| Total other income expense net | -36.61700M | 234.50M | -132.29300M | -103.17300M | 145.99M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 2042.86M | 199.94M | 319.09M | 604.36M | 739.14M |
| Net income applicable to common shares | 2689.82M | 123.67M | 375.76M | 533.23M | 693.56M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 15456.52M | 10974.12M | 10450.95M | 9860.86M | 7581.67M |
| Intangible assets | 287.87M | 308.95M | 349.11M | 354.62M | 386.14M |
| Earning assets | - | - | - | - | - |
| Other current assets | 234.96M | 132.68M | 116.43M | 162.81M | 1443.10M |
| Total liab | 7265.68M | 5168.51M | 5982.35M | 5767.28M | 3822.57M |
| Total stockholder equity | 7982.63M | 5625.27M | 4268.23M | 3932.25M | 3585.32M |
| Deferred long term liab | 480.77M | 353.28M | 394.85M | - | 382.98M |
| Other current liab | 686.89M | 836.43M | 513.95M | 624.38M | 875.88M |
| Common stock | 1.17M | 1.17M | 1.07M | 1.06M | 1.06M |
| Capital stock | 1.17M | 1.17M | 1.07M | 1.06M | 1.06M |
| Retained earnings | 5601.28M | 3096.54M | 3155.25M | 2943.48M | 2566.05M |
| Other liab | 1210.42M | 1289.86M | 1413.12M | 1380.68M | 1241.48M |
| Good will | 1617.63M | 1597.63M | 1665.52M | 1578.79M | 1567.17M |
| Other assets | 122.39M | 451.11M | 219.27M | 79.20M | 80.14M |
| Cash | 1499.14M | 439.27M | 746.72M | 613.11M | 555.32M |
| Cash and equivalents | 1499.14M | 439.27M | 746.72M | 613.11M | 555.32M |
| Total current liabilities | 2741.01M | 1874.34M | 1801.85M | 1409.00M | 1183.17M |
| Current deferred revenue | - | - | 394.85M | - | -522.51600M |
| Net debt | 1717.96M | 1954.97M | 2825.33M | 2460.28M | 1149.89M |
| Short term debt | 2.13M | 389.92M | 804.68M | 210.47M | 307.29M |
| Short long term debt | 2.13M | 389.92M | 804.68M | 187.34M | 307.29M |
| Short long term debt total | 3217.10M | 2394.24M | 3572.06M | 3073.39M | 1705.21M |
| Other stockholder equity | 2940.84M | 2920.01M | 1438.04M | 1383.45M | 1368.90M |
| Property plant equipment | 7091.17M | 5909.62M | 5354.62M | 5043.34M | 3021.08M |
| Total current assets | 5186.92M | 2007.98M | 2206.18M | 2225.11M | 1998.42M |
| Long term investments | 1150.55M | 897.71M | 656.24M | 579.81M | 528.72M |
| Net tangible assets | 7982.63M | 3718.69M | 4268.23M | 1998.84M | 1632.01M |
| Short term investments | - | 897.71M | 656.24M | - | - |
| Net receivables | 1376.79M | 623.11M | 592.80M | 680.20M | 697.89M |
| Long term debt | 3214.97M | 2004.32M | 2767.38M | 2804.03M | 1397.92M |
| Inventory | 2076.03M | 812.92M | 750.24M | 768.98M | 700.54M |
| Accounts payable | 2052.00M | 647.99M | 483.22M | 574.14M | 522.52M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | 208.22M | 180.34M | 200.37M | - | 173.79M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -560.66200M | -392.45000M | -326.13200M | -395.73500M | -350.68200M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | 1.17M | 1.17M | 1.07M | 1.06M | 1.06M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | 5601.28M | 3096.54M | 3155.25M | - | 2566.05M |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 204.12M | 233.44M | 198.95M | 197.79M | 63.11M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 10269.60M | 8966.14M | 8244.76M | 7635.75M | 5583.25M |
| Capital lease obligations | 99.27M | 127.00M | 116.77M | 137.82M | - |
| Long term debt total | 3214.97M | 2004.32M | 2767.38M | 2862.92M | 1397.92M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -0.70600M | -666.59000M | 8.57M | -1663.62500M | -5.87000M |
| Change to liabilities | 1287.07M | 143.94M | -31.51900M | -12.23400M | 73.73M |
| Total cashflows from investing activities | -1422.64900M | -666.59000M | -863.57300M | -1663.62500M | -303.69500M |
| Net borrowings | 851.08M | -1112.83200M | 335.85M | 1296.23M | -113.56700M |
| Total cash from financing activities | 611.89M | 50.21M | 177.26M | 1042.69M | -786.52600M |
| Change to operating activities | -306.01100M | 144.48M | -207.10900M | -37.58100M | -4.18000M |
| Net income | 2815.13M | 199.94M | 446.62M | 604.36M | 739.14M |
| Change in cash | 1059.87M | -307.45200M | 133.61M | 57.79M | -581.98300M |
| Begin period cash flow | 439.27M | 746.72M | 613.11M | 555.32M | 1137.30M |
| End period cash flow | 1499.14M | 439.27M | 746.72M | 613.11M | 555.32M |
| Total cash from operating activities | 1907.85M | 344.26M | 798.91M | 719.37M | 546.16M |
| Issuance of capital stock | 0.00000M | 1453.89M | - | - | - |
| Depreciation | 300.84M | 254.00M | 231.98M | 213.48M | 200.70M |
| Other cashflows from investing activities | -160.29700M | 287.08M | -21.66900M | -811.82900M | 402.17M |
| Dividends paid | -184.42900M | -177.85300M | -161.81800M | -152.20400M | 144.60M |
| Change to inventory | -1609.64200M | -127.40100M | 51.98M | -46.30400M | -124.06700M |
| Change to account receivables | -786.12100M | -49.29500M | 100.12M | -18.22000M | -97.44800M |
| Sale purchase of stock | 2.78M | 79.38M | 40.44M | 4.81M | -500.00000M |
| Other cashflows from financing activities | 1890.19M | -131.38300M | 589.08M | 1496.47M | -31.99600M |
| Change to netincome | 856.17M | -145.13700M | 334.37M | 87.00M | -152.44300M |
| Capital expenditures | 1261.65M | 953.67M | 850.48M | 851.80M | 699.99M |
| Change receivables | -786.12100M | -49.29500M | 100.12M | - | -97.44800M |
| Cash flows other operating | -955.60400M | 184.64M | -334.63000M | - | -93.44400M |
| Exchange rate changes | - | - | - | - | -37.92700M |
| Cash and cash equivalents changes | 1097.09M | -272.12100M | 112.60M | - | -581.98300M |
| Change in working capital | -1414.70200M | 111.72M | -86.53200M | -114.33900M | -151.96500M |
| Stock based compensation | 30.47M | 20.12M | 22.84M | 19.68M | 15.23M |
| Other non cash items | 82.77M | -203.02700M | 185.99M | -18.20200M | -306.09900M |
| Free cash flow | 646.20M | -609.41000M | -51.56300M | -132.42200M | -153.82600M |
Sector: Basic Materials Industry: Specialty Chemicals
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ALB Albemarle Corp |
-0.57 0.52% | 108.98 | 5.40 | 9.67 | 1.69 | 1.69 | 1.90 | 7.49 |
| LIN Linde plc Ordinary Shares |
3.48 0.77% | 453.62 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
0.03 0.09% | 33.36 | 29.34 | 24.57 | 3.42 | 3.95 | 3.87 | 15.91 |
| AIQUF L'Air Liquide S.A |
- -% | 166.59 | 29.39 | 24.69 | 3.41 | 3.97 | 3.87 | 15.91 |
| SHW Sherwin-Williams Co |
11.30 3.04% | 382.96 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based products used in fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
4250 Congress Street, Charlotte, NC, United States, 28209
| Name | Title | Year Born |
|---|---|---|
| Mr. Jerry Kent Masters Jr. | Chairman, Pres & CEO | 1961 |
| Mr. Scott A. Tozier | Exec. VP & CFO | 1966 |
| Ms. Karen G. Narwold Esq. | Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. | 1960 |
| Mr. Eric W. Norris | Pres of Lithium Global Bus. Unit | 1967 |
| Mr. Netha N. Johnson Jr. | Pres of Bromine Specialties Global Bus. Unit | 1971 |
| Mr. John Clarence Barichivich III | VP, Corp. Controller & Chief Accounting Officer | 1968 |
| Mr. Patrick Thompson | Chief Information Officer | NA |
| Ms. Melissa H. Anderson | Sr. VP & Chief HR Officer | 1965 |
| Mr. Ahmad Khalifeh | Managing Director of Middle East Office | NA |
| Mr. Raphael Goszcz Crawford | Pres of Catalysts Global Bus. Unit | 1976 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA 
AU
UK
US
NZ
Please wait processing your request...